The Chemours Company (CC)
| Market Cap | 2.30B +2.7% |
| Revenue (ttm) | 5.80B -0.9% |
| Net Income | -304.00M |
| EPS | -2.03 |
| Shares Out | 150.50M |
| PE Ratio | n/a |
| Forward PE | 10.12 |
| Dividend | $0.35 (2.29%) |
| Ex-Dividend Date | Aug 14, 2026 |
| Volume | 1,191,682 |
| Open | 15.26 |
| Previous Close | 15.48 |
| Day's Range | 15.16 - 15.61 |
| 52-Week Range | 10.44 - 28.67 |
| Beta | 1.42 |
| Analysts | Buy |
| Price Target | 19.78 (+29.28%) |
| Earnings Date | Aug 4, 2026 |
About CC
The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. The company operates through three segments: Thermal & Specialized Solutions, Titanium Technologies, and Advanced Performance Materials. The Thermal & Specialized Solutions segment provides refrigerants, thermal management solutions, propellants, foam blowing agents, and specialty solvents under the Freon and Opteon brand names. The Titanium Technologies segment offers TiO2 pigment, a white pigment that del... [Read more]
Financial Performance
Financial StatementsAnalyst Summary
According to 9 analysts, the average rating for CC stock is "Buy." The 12-month stock price target is $19.78, which is an increase of 29.28% from the latest price.
News
Chemours Publishes 2025 Sustainability Report Highlighting Progress on Climate, Emissions Reduction, and Responsible Manufacturing
WILMINGTON, Del., Aug. 25, 2026 /PRNewswire/ -- The Chemours Company (Chemours) (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solutions (TSS), Titanium ...
Chemours price target lowered to $17 from $19 at Goldman Sachs
Goldman Sachs analyst Duffy Fischer lowered the firm’s price target on Chemours (CC) to $17 from $19 and keeps a Neutral rating on the shares. The firm raised estimates on…
Chemours price target lowered to $18 from $26 at BMO Capital
BMO Capital lowered the firm’s price target on Chemours (CC) to $18 from $26 and keeps an Outperform rating on the shares after its Q2 results last week. The company’s…
Chemours price target lowered to $15 from $22 at JPMorgan
JPMorgan lowered the firm’s price target on Chemours (CC) to $15 from $22 and keeps a Neutral rating on the shares.
Chemours price target lowered to $18 from $21 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Chemours (CC) to $18 from $21 and keeps an Equal Weight rating on the shares.
Chemours price target lowered to $18 from $21 at Morgan Stanley
Morgan Stanley analyst Vincent Andrews lowered the firm’s price target on Chemours (CC) to $18 from $21 and keeps an Equal Weight rating on the shares following Q2 results that…
Chemours Launches Opteon™ ZE and Opteon™ 515B Refrigerants for Chiller Applications Powering Data Centers, Commercial Buildings, and Other Mission Critical Environments
New additions to the Opteon™ portfolio support high-performance, sustainable cooling solutions in stationary chillers for AI-driven data centers, and commercial HVAC applications WILMINGTON, Del., Aug...
Chemours downgraded to Neutral from Buy at UBS
UBS analyst Joshua Spector downgraded Chemours (CC) to Neutral from Buy with a price target of $18, down from $29. The company’s recent results leave more questions around the right…
New Jersey's $2.5 billion 'forever chemicals' settlements with DuPont, 3M, others win court approval
A federal judge on Friday approved more than $2.5 billion of settlements that New Jersey reached with DuPont , Chemours , Corteva and 3M to resolve claims over pollution attributed to PFAS, also know...
Chemours price target lowered to $24 from $30 at Truist
Truist analyst Peter Osterland lowered the firm’s price target on Chemours (CC) to $24 from $30 and keeps a Buy rating on the shares.
Chemours price target lowered to $22 from $26 at RBC Capital
RBC Capital lowered the firm’s price target on Chemours (CC) to $22 from $26 and keeps an Outperform rating on the shares.
The Chemours Company Earnings Call Transcript: Q2 2026
Disciplined execution and pricing actions drove adjusted EBITDA above expectations, despite softer TSS aftermarket demand and inflationary pressures. Strategic transformation and debt reduction continue, with strong growth in high-value markets like data centers and semiconductors.
The Chemours Company Earnings release: Q2 2026
The Chemours Company released its Q2 2026 earnings on August 5, 2026, summarizing the period's financial results.
The Chemours Company Slides: Q2 2026
The Chemours Company has posted slides in relation to its Q2 2026 quarterly earnings report, which was published on August 5, 2026.
The Chemours Company Quarterly report: Q2 2026
The Chemours Company has published its Q2 2026 quarterly earnings report on August 5, 2026.
Chemours price target lowered to $22 from $25 at Mizuho
Mizuho lowered the firm’s price target on Chemours (CC) to $22 from $25 and keeps an Outperform rating on the shares.
Chemours Announces Third Quarter Dividend
WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours") (NYSE: CC) today announced that the Board of Directors of Chemours declared a quarterly cash dividend of $0.0875 per sh...
The Chemours Company Reports Second Quarter Results
WILMINGTON, Del., Aug. 4, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC), a global chemistry company with leading market positions in Thermal & Specialized Solution...
Chemours Announces Dates for Second Quarter 2026 Earnings Release and Webcast Conference Call
WILMINGTON, Del., July 23, 2026 /PRNewswire/ -- The Chemours Company ("Chemours" or "the Company") (NYSE: CC) today announced that the Company expects to issue its second quarter 2026 financial result...
NY AG sues 3M, Corteva, DuPont over toxic pollution from consumer products
New York Attorney General Letitia James sued some of the nation’s largest chemical and agricultural companies – 3M Company (MMM), EIDP, The Chemours Company (CC), Corteva, Inc. (CTVA), and DuPont…
Chemours price target lowered to $25 from $30 at Mizuho
Mizuho lowered the firm’s price target on Chemours (CC) to $25 from $30 and keeps an Outperform rating on the shares. The firm lowered price targets for most of its…
Virtune adds four new crypto assets to the Virtune Stablecoin Index ETP: Ethena (ENA), Canton (CC), TRON (TRX), and BNB (BNB)
Stockholm, July 1st, 2026 – Virtune today announces the completion of the rebalancing for the Virtune Stablecoin Index ETP (SE0026821282), listed on Nasdaq Stockholm, Nasdaq Helsinki and Xetra.
Chemours announces agreement with U.S. EPA to resolve claims relating to PFAS
Chemours (CC) announced a settlement to resolve claims asserted by the U.S. Environmental Protection Agency relating to PFAS discharges and other alleged non-compliance actions, primarily at the compa...
Chemours Reaches Agreement with U.S. EPA to Resolve Claims Relating to PFAS
The settlement resolves the federal government's claims relating to discharge of PFAS compounds across three current operating sites, as well as certain environmental claims by the State of West Virgi...
Chemours to pay $450M to settle DOJ, EPA, WV DEP claims
The Justice Department, Environmental Protection Agency, and West Virginia Department of Environmental Protection announced a multi-state settlement with The Chemours (CC) Company under the Clean Wate...